DUBLIN--(BUSINESS WIRE)--The "Antithrombin Market by : Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022" report has been added to ResearchAndMarkets.com's offering.
The report covers forecast and analysis for the antithrombin market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million).
The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions mergers, new technology launch, agreements, partnerships, collaborations joint ventures, research development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.
The study provides a decisive view on the antithrombin market by segmenting the market based on source, application, dosage form, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2014 to 2022. Based on the source the market is segmented into human, and goat milk. Key application covered under this study includes diagnostics, therapeutics, and research. By dosage form, the market is segmented into liquid and lyophilized.
Scope of the Report
Global Antithrombin Market: Source Segment Analysis:
- Goat Milk
Global Antithrombin Market: Application Segment Analysis:
Global Antithrombin Market: Dosage Form Segment Analysis:
- rEVO Biologics, Inc.
- Kedrion S.p.A
- CSL Limited
- Scripps Laboratories Inc.
- Lee BioSolutions
For more information about this report visit https://www.researchandmarkets.com/research/sphz2r/global?w=4